Study Overview
Fei Wang, PhD, of Breakthrough T1D in St. Leonards, Australia, and colleagues released a cross-sectional study in 2024 that exposes striking state-by-state differences in Type 1 diabetes incidence and care. The comprehensive analysis draws on national data to show that where a child lives can significantly shape their disease risk and access to specialized treatment. These findings underscore critical gaps in health equity across the United States.
Incidence Rates Vary Widely by State
In 2024, the national incidence rate of Type 1 diabetes was 24.0 per 100,000 persons under age 20, yet this national figure conceals a wide range. This rate reflects new diagnoses over the course of the year. Fei Wang, PhD, and colleagues reported that state-level rates oscillated from 17.0 to 27.8 per 100,000. These numbers were derived from a sophisticated modeling approach that pooled data from multiple sources. The sheer variation from state to state indicates that local factors may be driving disease onset.
States with the Lowest Incidence
The lowest rates were found in:
- Hawaii: 17.0 per 100,000
- New Mexico: 20.5 per 100,000
- California: 20.6 per 100,000
These figures stand well below the national average. The source did not provide details on why these states show reduced rates, but geographic and demographic differences likely play a part. Public health researchers may look to these regions for clues on protective factors.
States with the Highest Incidence
On the opposite end, the highest rates were recorded in:
- West Virginia: 27.8 per 100,000
- Maine: 27.4 per 100,000
- Vermont: 27.4 per 100,000
These northeastern states and West Virginia appear to carry a heavier burden of youth diabetes. The reasons for these elevated rates remain unclear in the analysis. But incidence is only part of the story; access to specialized medical professionals tells an equally concerning tale.
Access to Pediatric Endocrinologists Differs Dramatically
The ratio of board-certified pediatric endocrinologists to patients with Type 1 diabetes also varied widely across the country. Wang’s team identified marked disparities in access to specialized care, with some states critically underserved. These specialists are essential for managing the complex needs of young patients with Type 1 diabetes. Without adequate access, families can face significant obstacles in receiving timely and effective treatment.
States with Severe Shortages
In the most extreme cases, the following states each had fewer than five pediatric endocrinologists per 1,000 patients younger than 18:
- Nebraska
- Mississippi
- North Dakota
- New Mexico
This means that hundreds of families may rely on a single specialist or be forced to travel across state lines for care. The source did not provide details on the exact patient volumes, but the implications for daily management are profound. Such shortages can delay diagnosis, complicate insulin regimen adjustments, and reduce educational support.
States with Abundant Specialists
In stark contrast, some areas had a much higher concentration of specialists:
- Washington, D.C.: 46.4 per 1,000 patients
- Rhode Island: 22.5 per 1,000 patients
- Massachusetts: 20.7 per 1,000 patients
These areas benefit from academic medical centers and robust healthcare networks. To better understand the underlying patterns in incidence and care, researchers turned to robust data sources and modeling.
Study Methodology and Data Sources
A cross-sectional study indicated wide variations in the numbers of Type 1 diabetes patients and specialists throughout the U.S. In this analysis, the researchers applied the Type 1 Diabetes Index model to estimated incidence figures using data from the U.S. SEARCH for Diabetes in Youth Study. They also incorporated adult incidence estimates and publicly available state demographic data regarding age, race, and ethnicity. This approach allowed them to generate state-level snapshots that reflect real-world patterns, though certain constraints apply.
The integration of youth and adult data helped paint a fuller picture of the disease landscape. However, the source did not provide details on how the model accounted for potential biases or missing information. Such modeling efforts are common in public health research to fill knowledge gaps. As with any large-scale analysis, the study carried inherent limitations.
Limitations and the Path Forward
Study limitations included gaps in available data and varying diagnostic criteria used for adult populations. The source did not provide details on how these factors might skew results, but such issues are common in epidemiological research. Incomplete data can lead to underestimation or overestimation of true incidence. Researchers often note that adult Type 1 diabetes is sometimes misclassified as type 2, adding to the uncertainty.
What Families Can Do
For families navigating these disparities, consulting a healthcare professional remains essential for personalized guidance. The study highlights that where you live can influence your child’s care options. Parents in low-access states should be proactive in seeking telehealth or traveling for specialist visits if needed. Early and consistent care is key to managing Type 1 diabetes successfully.
A Call for Policy Action
The evidence underscores the urgent need for policies that bridge care divides across states. These findings serve as a call to action for policymakers to address specialist shortages and incidence hotspots. Bridging these divides will require targeted investments and community-level interventions. Without such measures, the disparity gaps may continue to widen.
Source
- www.medpagetoday.com
- JAMA Network Open (jamanetwork.com)
- U.S. SEARCH for Diabetes in Youth Study (www.searchfordiabetes.org)
- comments powered by Disqus. (disqus.com)
